Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors - Ursan, I D; Jiang, R; Pickard, E M; Lee, T A; Ng, D; Pickard, A S (J Manag Care Spec Pharm, 2015)